James F. Polewaczyk - 07 Dec 2023 Form 4 Insider Report for IDEXX LABORATORIES INC /DE (IDXX)

Role
Executive Vice President
Signature
/s/ Lily J. Lu, Attorney-in-Fact for James F. Polewaczyk
Issuer symbol
IDXX
Transactions as of
07 Dec 2023
Net transactions value
-$3,116,855
Form type
4
Filing time
08 Dec 2023, 17:00:21 UTC
Previous filing
31 Aug 2023
Next filing
16 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IDXX Common Stock Options Exercise $1,025,595 +4,956 +49% $206.94 15,006 07 Dec 2023 Direct F1
transaction IDXX Common Stock Options Exercise $1,929,050 +6,680 +45% $288.78 21,686 07 Dec 2023 Direct
transaction IDXX Common Stock Sale $1,620,919 -3,116 -14% $520.19 18,570 07 Dec 2023 Direct F2
transaction IDXX Common Stock Sale $1,759,954 -3,378 -18% $521.00 15,192 07 Dec 2023 Direct F3
transaction IDXX Common Stock Sale $627,816 -1,202 -7.9% $522.31 13,990 07 Dec 2023 Direct F4
transaction IDXX Common Stock Sale $2,062,812 -3,940 -28% $523.56 10,050 07 Dec 2023 Direct F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IDXX Non-Qualified Stock Option (right-to-buy) Options Exercise $0 -4,956 -87% $0.000000 755 07 Dec 2023 Common Stock 4,956 $206.94 Direct F6
transaction IDXX Non-Qualified Stock Option (right-to-buy) Options Exercise $0 -6,680 -75% $0.000000 2,226 07 Dec 2023 Common Stock 6,680 $288.78 Direct F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 12 shares purchased under the Issuer's Employee Stock Purchase Plan on September 29, 2023.
F2 Represents the weighted average price of the shares sold ranging from a low of $519.73 to a high of $520.73 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
F3 Represents the weighted average price of the shares sold ranging from a low of $520.74 to a high of $521.235 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
F4 Represents the weighted average price of the shares sold ranging from a low of $521.99 to a high of $522.935 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
F5 Represents the weighted average price of the shares sold ranging from a low of $523.05 to a high of $523.885 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
F6 Grant of option to buy 5,711 shares of Issuer common stock that vest in five annual installments beginning February 14, 2020.
F7 Grant of option to buy 8,906 shares of Issuer common stock that vest in four annual installments beginning February 14, 2021.